Joseph, G.; Klein, E.; Lustig, Y.; Weiss-Ottolenghi, Y.; Asraf, K.; Indenbaum, V.; Amit, S.; Kriger, O.; Gilboa, M.; Levy, Y.;
et al. Real-World Immunogenicity and Reactogenicity of Two Doses of Pfizer-BioNTech COVID-19 Vaccination in Children Aged 5–11 Years. Vaccines 2022, 10, 1954.
https://doi.org/10.3390/vaccines10111954
AMA Style
Joseph G, Klein E, Lustig Y, Weiss-Ottolenghi Y, Asraf K, Indenbaum V, Amit S, Kriger O, Gilboa M, Levy Y,
et al. Real-World Immunogenicity and Reactogenicity of Two Doses of Pfizer-BioNTech COVID-19 Vaccination in Children Aged 5–11 Years. Vaccines. 2022; 10(11):1954.
https://doi.org/10.3390/vaccines10111954
Chicago/Turabian Style
Joseph, Gili, Elisheva Klein, Yaniv Lustig, Yael Weiss-Ottolenghi, Keren Asraf, Victoria Indenbaum, Sharon Amit, Or Kriger, Mayan Gilboa, Yuval Levy,
and et al. 2022. "Real-World Immunogenicity and Reactogenicity of Two Doses of Pfizer-BioNTech COVID-19 Vaccination in Children Aged 5–11 Years" Vaccines 10, no. 11: 1954.
https://doi.org/10.3390/vaccines10111954
APA Style
Joseph, G., Klein, E., Lustig, Y., Weiss-Ottolenghi, Y., Asraf, K., Indenbaum, V., Amit, S., Kriger, O., Gilboa, M., Levy, Y., Pessach, I. M., Kreiss, Y., Regev-Yochay, G., & Stein, M.
(2022). Real-World Immunogenicity and Reactogenicity of Two Doses of Pfizer-BioNTech COVID-19 Vaccination in Children Aged 5–11 Years. Vaccines, 10(11), 1954.
https://doi.org/10.3390/vaccines10111954
